Archive for September, 2012

Researchers discover way to detect and eliminate troublemaking stem cells

Mayo Clinic researchers have found a way to detect and eliminate potentially troublemaking stem cells to make stem cell therapy safer. Induced Pluripotent Stem cells, also known as iPS cells, are bioengineered from adult tissues to have properties of embryonic stem cells, which have the unlimited capacity to differentiate and grow into any desired types of cells, such as skin, brain, lung and …

Cytori’s Stem Cell Therapy for Burns Wins U.S. Contract

Cytori Therapeutics Inc. (CYTX) , a biotechnology company with $10 million in annual revenue, won a $4.7 million U.S. government contract to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs.

The great stem cell dilemma

Breakthroughs promise a new era in medicine, and billionaire donors like Eli Broad and Bill Gross are lending support. But not even Andy Grove can figure out how to make the business work.

BioTime Forms BioTime Acquisition Corporation Subsidiary will seek to acquire assets and businesses in the stem cell and regenerative medicine fields

ALAMEDA, Calif., Sep 28, 2012 (BUSINESS WIRE) — –Dr. Thomas Okarma appointed Chief Executive Officer of the new company BioTime, Inc. (NYSE MKT: BTX), an Alameda-based company engaged in research and development of innovative new products in the field of …

The Line Between Embryonic And Pluripotent Stem Cell Research Is Blurring

Over at Stem Cell Network, Paul Krzyzanowski wonders whether Barack Obama and Mitt Romney will be asked about their support for stem cell research during the presidential debates. He notes one reason the topic may not be broached is that many …

Of Wrestlers, Arthritis and Republicans: Conn. Senate Candidate Linda McMahon May Block Stem Cell Research

Republican gazillionaire Linda McMahon is running for the Connecticut Senate. Her last Senatorial campaign, (on which she spent over $50 million dollars), described her as a “tough CEO” which seems accurate; this year’s campaign re-introduces …

Purging Stem Cells To Make Therapy Safer

A sticky problem that is holding back the therapeutic use of stem cells bioengineered from adult tissue (induced pluripotent stem cells or iPS cells), is the risk that any residual undifferentiated ones will remain and form tumors after transplant into the patient. So while iPS stem cell therapy may be effective, as long as this problem remains, it is unsafe…

Stem Cell Transplants Can Now Be Performed with Fewer Risks

Researchers at the Washington University in St. Louis (WUSL) say that data collected during a new study conducted on unsuspecting lab mice may soon help doctors perform stem cells transplants that have fewer deadly complications and negative side-effects …

MiR-214 plays a critical role in regulating ovarian cancer stem cell properties

Researchers at Moffitt Cancer Center have discovered that the micro ribonucleic acid miR-214 plays a critical role in regulating ovarian cancer stem cell properties. This knowledge, said the researchers, could pave the way for a therapeutic target for ovarian cancer.

Safe Stem Cells Reverse Alzheimer’s Symptoms, Neuropathy

Scientists in South Korea have used intravenous injections of human adipose-derived stem cells (hADSCs) to both prevent development of and reverse the symptoms and neuropathology of Alzheimer’s disease (AD) in mouse models. The studies, in the …